Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FX7F5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,082.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,082.93 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 68 mg Nexplanon implants. This delivery order, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The award falls under the company's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical and medical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical system, maintaining a comprehensive product portfolio spanning branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. Under the PPV-G GEN V prime vendor contract awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036, the company is authorized to fulfill diverse and specialized pharmaceutical requirements across military healthcare operations globally. The current delivery order for Nexplanon implants exemplifies the company's role in supplying specialized contraceptive devices and other critical medications essential to DoD medical operations.
Quick answers
Who was awarded contract SPE2DB26FX7F5?
SPE2DB26FX7F5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FX7F5 worth?
The government has obligated $2,083 on SPE2DB26FX7F5.
Is contract SPE2DB26FX7F5 an order under another contract?
Yes. SPE2DB26FX7F5 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB26FX7F5 competed?
The extent of competition for SPE2DB26FX7F5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award